Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P54289: Variant p.Gly209Asp

Voltage-dependent calcium channel subunit alpha-2/delta-1
Gene: CACNA2D1
Feedback?
Variant information Variant position: help 209 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Aspartate (D) at position 209 (G209D, p.Gly209Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In DEE110; does not promote calcium currents in transfected cells indicating loss of function in the positive regulation of voltage-gated calcium channel activity; severely decreased localization at the cell membrane; undergoes limited proteolytic cleavage. Any additional useful information about the variant.


Sequence information Variant position: help 209 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1103 The length of the canonical sequence.
Location on the sequence: help LDEVFKKNREEDPSLLWQVF G SATGLARYYPASPWVDNSRT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRT

Mouse                         LDEVFKRNRDEDPTLLWQVFGSATGLARYYPASPWVDNSRT

Rat                           LDEVFKRNRDEDPTLLWQVF-AADRLARYYPASPWVDNSRT

Rabbit                        LDDVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRT
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 25 – 1103 Voltage-dependent calcium channel subunit alpha-2/delta-1
Chain 25 – 956 Voltage-dependent calcium channel subunit alpha-2-1
Topological domain 25 – 1073 Extracellular
Beta strand 206 – 210



Literature citations
Biallelic CACNA2D1 loss-of-function variants cause early-onset developmental epileptic encephalopathy.
Dahimene S.; von Elsner L.; Holling T.; Mattas L.S.; Pickard J.; Lessel D.; Pilch K.S.; Kadurin I.; Pratt W.S.; Zhulin I.B.; Dai H.; Hempel M.; Ruzhnikov M.R.Z.; Kutsche K.; Dolphin A.C.;
Brain 145:2721-2729(2022)
Cited for: VARIANT DEE110 ASP-209; CHARACTERIZATION OF VARIANT DEE110 ASP-209; FUNCTION; SUBCELLULAR LOCATION; INVOLVEMENT IN DEE110;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.